Sensyne, University of Oxford to use AI and data science to evaluate NHS patient data

Sensyne Health plc (LSE:SENS) partnered with Univeristy of Oxford's Big Data Institute (BDI) in a three-year deal to use artificial intelligence and data science for patient-centered management and treatment of chronic disease. The partners will develop and analyze automated, real-time translation of physician notes utilizing Sensyne's access to anonymized longitudinal data sets from the NHS Trust. The partners' initial focus is on kidney and cardiovascular diseases.

Sensyne said resulting products and royalties under the deal will be shared with NHS Trust and the University of Oxford...